Galderma
Global dermatology company spanning therapeutics, aesthetics and skincare.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Galderma Group AG
- Entity type
- COMPANY
- Founded
- 1981
- Headquarters
- Zählerweg 10, 6300 Zug, Switzerland
- Company size
- >5,000
- Market role
- Advertiser / Brand
- Ticker
- GALD (SIX)
- Official website
- galderma.com
What Galderma does
Galderma creates value by researching, developing, manufacturing and commercialising dermatology-focused products across prescription therapeutics, injectable aesthetics and skincare. It monetises this portfolio through product sales into professional healthcare channels and consumer skincare channels, using brand equity, clinical positioning and global distribution to drive repeat demand.
Category differentiation
Galderma is a dermatology products company, not an adtech, martech or software platform. It operates as a skin-health manufacturer and brand spanning therapeutics, aesthetics and skincare.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Galderma Group AG is a publicly listed pure-play dermatology company headquartered in Switzerland. It develops and sells prescription therapeutics, injectable aesthetic treatments and dermatological skincare products. The company operates globally and reported FY2025 net sales of USD 5.207 billion, indicating large-scale commercial execution across medical and consumer skin-health segments. Galderma generates revenue by selling branded dermatology products through healthcare, aesthetics and skincare channels. Its customers include dermatologists, aesthetic physicians and clinics, pharmacies, distributors, retailers and end-consumers purchasing skincare products. The business model combines medical-product sales with aesthetics and skincare demand, giving it exposure to both clinician-driven and consumer-led spending.
Company news briefing
Briefing updated:
Galderma has inaugurated its new United States and Latin America headquarters in Miami, centralising regional leadership for the Americas. This development facilitates the organisation’s operational management and coordination across these core geographic markets.
Business model & monetisation
Galderma primarily monetises through product sales. Revenue comes from prescription therapeutics sold via medical channels, injectable aesthetic treatments sold to clinics and physicians, and dermatological skincare sold through retail, pharmacy and professional channels. The commercial model is based on recurring replenishment and repeat purchase rather than subscriptions or advertising.
- Dermatological product sales
- One-time Sale
- Injectable aesthetic treatment sales
- One-time Sale
- Dermatological skincare sales
- One-time Sale
Products & capabilities
No products with linked sources are available in this view.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Galderma opens new U.S. and Latin America headquarters in Miami
Recorded impact score: 4/5
Explore company relationships
Questions about Galderma
What is Galderma?
Galderma is a publicly listed pure-play dermatology company that develops and sells prescription therapeutics, injectable aesthetic treatments and dermatological skincare products.
Who uses Galderma?
Galderma serves dermatologists, aesthetic physicians, clinics, pharmacies, retailers, distributors and consumers who buy skincare products.
How does Galderma make money?
Galderma makes money by selling dermatology products across therapeutic, injectable aesthetics and skincare categories through medical and consumer channels.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
11 publicly documented primary sources and citations linked across the market graph.
Continue your research on Galderma
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.